이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

고위험 골수이형성 증후군 또는 만성 골수단구성 백혈병 환자 치료에서 레날리도마이드 또는 보리노스타트 병용 또는 병용 아자시티딘

2026년 11월 17일 업데이트: National Cancer Institute (NCI)

고위험 골수이형성 증후군(MDS) 및 만성 골수단구성 백혈병(CMML)에 대한 레날리도마이드(NSC-703813)와 병용한 아자시티딘 대 아자시티딘 단독 대 보리노스타트(NSC-701852)와 병용한 아자시티딘의 무작위 II/III상 연구

This randomized phase II/III trial studies how well azacitidine works with or without lenalidomide or vorinostat in treating patients with higher-risk myelodysplastic syndromes or chronic myelomonocytic leukemia. Drugs used in chemotherapy, such as azacitidine, work in different ways to stop the growth of cancer cells, either by killing the cells, stopping them from dividing, or by stopping them from spreading. Lenalidomide may stop the growth of cancer cells by stopping blood flow to the cancer. Vorinostat may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. It is not yet known whether azacitidine is more effective with or without lenalidomide or vorinostat in treating myelodysplastic syndromes or chronic myelomonocytic leukemia.

연구 개요

상세 설명

PRIMARY OBJECTIVES:

I. To select based on response rate (complete remission, partial remission, or hematologic improvement) either the combination of lenalidomide and azacitidine or the combination of vorinostat and azacitidine for further testing against single-agent azacitidine among patients with higher-risk myelodysplastic syndromes (MDS) or chronic myelomonocytic leukemia (CMML). (Phase II) II. To compare overall survival between the combination arm selected in the Phase II portion of the trial to single-agent azacitidine among patients with higher-risk myelodysplastic syndromes (MDS) or chronic myelomonocytic leukemia (CMML). (Phase III)

SECONDARY OBJECTIVES:

I. To estimate relapse-free survival, overall survival and cytogenetic response rate of patients treated on each regimen.

II. To estimate the frequency and severity of toxicities of the three regimens in this patient population.

III. To investigate in a preliminary manner the frequency of subgroups from prestudy cytogenetic studies and correlate these subgroups with clinical outcomes in this patient population.

IV. To collect specimens for banking for use in future research studies.

TERTIARY OBJECTIVES:

I. To evaluate the prevalence of a pre-specified list of molecular lesions (48 total lesions).

II. To assess associations of these lesions with outcomes (response, event-free survival, relapse-free survival, and overall survival).

III. To develop a deoxyribonucleic acid (DNA) methylation biomarker predictive of response to DMTi treatment in MDS.

IV. To harness gene expression profiles as clinical biomarkers of primary resistance to DMTi in MDS.

OUTLINE: Patients are randomized to 1 of 3 treatment arms. In Phase III, patients are randomized to 1 of 2 treatment arms (the combination arm selected in Phase II or the single-agent azacitidine arm).

ARM I: Patients receive azacitidine subcutaneously (SC) or intravenously (IV) on days 1-7 or days 1-5 and 8-9, and lenalidomide orally (PO) once daily (QD) on days 1-21.

ARM II: Patients receive azacitidine as in Arm I.

ARM III: Patients receive azacitidine as in Arm I and vorinostat PO twice daily (BID) on days 3-9.

In all arms, treatment repeats every 28 days for up to 5 years in the absence of disease progression or unacceptable toxicity.

After completion of study treatment, patients are followed up every 3 months for up to 5 years.

연구 유형

중재적

등록 (실제)

282

단계

  • 2 단계

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 장소

    • Alabama
      • Birmingham, Alabama, 미국, 35233
        • University of Alabama at Birmingham Cancer Center
      • Mobile, Alabama, 미국, 36688
        • University of South Alabama Mitchell Cancer Institute
    • Arizona
      • Scottsdale, Arizona, 미국, 85259
        • Mayo Clinic in Arizona
      • Tucson, Arizona, 미국, 85719
        • Banner University Medical Center - Tucson
      • Tucson, Arizona, 미국, 85719
        • University of Arizona Cancer Center-North Campus
    • Arkansas
      • Little Rock, Arkansas, 미국, 72205
        • John L McClellan Memorial Veterans Hospital
    • California
      • Antioch, California, 미국, 94531
        • Kaiser Permanente-Deer Valley Medical Center
      • Duarte, California, 미국, 91010
        • City of Hope Comprehensive Cancer Center
      • Los Angeles, California, 미국, 90033
        • USC / Norris Comprehensive Cancer Center
      • Oakland, California, 미국, 94611
        • Kaiser Permanente-Oakland
      • Palo Alto, California, 미국, 94304
        • Stanford Cancer Institute Palo Alto
      • Richmond, California, 미국, 94801
        • Kaiser Permanente-Richmond
      • Sacramento, California, 미국, 95823
        • Kaiser Permanente-South Sacramento
      • Sacramento, California, 미국, 95825
        • Kaiser Permanente Sacramento Medical Center
      • San Francisco, California, 미국, 94115
        • Kaiser Permanente-San Francisco
      • San Jose, California, 미국, 95119
        • Kaiser Permanente-Santa Teresa-San Jose
      • San Rafael, California, 미국, 94903
        • Kaiser Permanente-San Rafael
      • Santa Clara, California, 미국, 95051
        • Kaiser Permanente Medical Center - Santa Clara
      • Santa Rosa, California, 미국, 95403
        • Kaiser Permanente-Santa Rosa
      • Santa Rosa, California, 미국, 95403
        • Sutter Pacific Medical Foundation
      • South San Francisco, California, 미국, 94080
        • Kaiser Permanente-South San Francisco
      • Vallejo, California, 미국, 94589
        • Kaiser Permanente-Vallejo
      • Walnut Creek, California, 미국, 94596
        • Kaiser Permanente-Walnut Creek
    • Colorado
      • Aurora, Colorado, 미국, 80012
        • The Medical Center of Aurora
      • Aurora, Colorado, 미국, 80045
        • UCHealth University of Colorado Hospital
      • Boulder, Colorado, 미국, 80303
        • Boulder Community Foothills Hospital
      • Colorado Springs, Colorado, 미국, 80907
        • Penrose-Saint Francis Healthcare
      • Denver, Colorado, 미국, 80218
        • Presbyterian - Saint Lukes Medical Center - Health One
      • Denver, Colorado, 미국, 80220
        • Rose Medical Center
      • Denver, Colorado, 미국, 80218
        • Rocky Mountain Cancer Centers-Midtown
      • Denver, Colorado, 미국, 80220
        • Rocky Mountain Cancer Centers-Rose
      • Denver, Colorado, 미국, 80218
        • Colorado Blood Cancer Institute
      • Denver, Colorado, 미국, 80222
        • Western States Cancer Research NCORP
      • Denver, Colorado, 미국, 80218
        • Saint Joseph Hospital - Cancer Centers of Colorado
      • Denver, Colorado, 미국, 80210
        • AdventHealth Porter
      • Durango, Colorado, 미국, 81301
        • Mercy Medical Center
      • Englewood, Colorado, 미국, 80113
        • Mountain Blue Cancer Care Center - Swedish
      • Englewood, Colorado, 미국, 80113
        • Swedish Medical Center
      • Fort Collins, Colorado, 미국, 80524
        • Poudre Valley Hospital
      • Golden, Colorado, 미국, 80401
        • Mountain Blue Cancer Care Center
      • Greeley, Colorado, 미국, 80631
        • Banner North Colorado Medical Center
      • Greenwood Village, Colorado, 미국, 80111
        • Rocky Mountain Cancer Centers-Greenwood Village
      • Lakewood, Colorado, 미국, 80228
        • Rocky Mountain Cancer Centers-Lakewood
      • Lakewood, Colorado, 미국, 80228
        • CommonSpirit Saint Anthony Hospital Cancer Center
      • Littleton, Colorado, 미국, 80122
        • AdventHealth Littleton
      • Lone Tree, Colorado, 미국, 80124
        • Sky Ridge Medical Center
      • Lone Tree, Colorado, 미국, 80124
        • Rocky Mountain Cancer Centers-Sky Ridge
      • Longmont, Colorado, 미국, 80501
        • Longmont United Hospital
      • Loveland, Colorado, 미국, 80539
        • Banner North Colorado Medical Center - Loveland Campus
      • Parker, Colorado, 미국, 80138
        • Rocky Mountain Cancer Centers-Parker
      • Parker, Colorado, 미국, 80138
        • AdventHealth Parker
      • Pueblo, Colorado, 미국, 81004
        • Saint Mary Corwin Medical Center
      • Wheat Ridge, Colorado, 미국, 80401
        • Intermountain Health Lutheran Hospital
    • Connecticut
      • Farmington, Connecticut, 미국, 06030
        • University of Connecticut
      • Hartford, Connecticut, 미국, 06105
        • Smilow Cancer Hospital Care Center at Saint Francis
      • New Britain, Connecticut, 미국, 06050
        • The Hospital of Central Connecticut
    • Delaware
      • Lewes, Delaware, 미국, 19958
        • Beebe Medical Center
      • Newark, Delaware, 미국, 19718
        • Christiana Care Health System-Christiana Hospital
    • District of Columbia
      • Washington D.C., District of Columbia, 미국, 20016
        • Sibley Memorial Hospital
      • Washington D.C., District of Columbia, 미국, 20422
        • Veterans Affairs Medical Center -Washington DC
    • Florida
      • Gainesville, Florida, 미국, 32610
        • UF Health Cancer Institute - Gainesville
      • Jupiter, Florida, 미국, 33458
        • Jupiter Medical Center
      • Miami Beach, Florida, 미국, 33140
        • Mount Sinai Medical Center
      • Orlando, Florida, 미국, 32803
        • AdventHealth Orlando
    • Georgia
      • Augusta, Georgia, 미국, 30912
        • Augusta University Medical Center
    • Hawaii
      • Honolulu, Hawaii, 미국, 96813
        • Hawaii Cancer Care Inc - Waterfront Plaza
      • Honolulu, Hawaii, 미국, 96813
        • Straub Clinic and Hospital
      • Honolulu, Hawaii, 미국, 96813
        • University of Hawaii Cancer Center
      • Honolulu, Hawaii, 미국, 96817
        • Queen's Cancer Center - Kuakini
      • Honolulu, Hawaii, 미국, 96819
        • Kaiser Permanente Moanalua Medical Center
    • Idaho
      • Boise, Idaho, 미국, 83706
        • Saint Alphonsus Cancer Care Center-Boise
      • Post Falls, Idaho, 미국, 83854
        • Kootenai Clinic Cancer Services - Post Falls
    • Illinois
      • Bloomington, Illinois, 미국, 61704
        • Illinois CancerCare-Bloomington
      • Canton, Illinois, 미국, 61520
        • Illinois CancerCare-Canton
      • Carthage, Illinois, 미국, 62321
        • Illinois CancerCare-Carthage
      • Chicago, Illinois, 미국, 60611
        • Northwestern University
      • Chicago, Illinois, 미국, 60637
        • University of Chicago Comprehensive Cancer Center
      • Chicago, Illinois, 미국, 60612
        • University of Illinois
      • Chicago, Illinois, 미국, 60611
        • Hematology and Oncology Associates
      • Decatur, Illinois, 미국, 62526
        • Decatur Memorial Hospital
      • Decatur, Illinois, 미국, 62526
        • Heartland Cancer Research NCORP
      • Eureka, Illinois, 미국, 61530
        • Illinois CancerCare-Eureka
      • Evanston, Illinois, 미국, 60201
        • NorthShore University HealthSystem-Evanston Hospital
      • Galesburg, Illinois, 미국, 61401
        • Illinois CancerCare-Galesburg
      • Havana, Illinois, 미국, 62644
        • Illinois CancerCare-Havana
      • Kewanee, Illinois, 미국, 61443
        • Illinois CancerCare-Kewanee Clinic
      • Macomb, Illinois, 미국, 61455
        • Illinois CancerCare-Macomb
      • Maywood, Illinois, 미국, 60153
        • Loyola University Medical Center
      • Moline, Illinois, 미국, 61265
        • Trinity Medical Center
      • Monmouth, Illinois, 미국, 61462
        • Illinois CancerCare-Monmouth
      • Normal, Illinois, 미국, 61761
        • Illinois CancerCare-Community Cancer Center
      • Ottawa, Illinois, 미국, 61350
        • Illinois CancerCare-Ottawa Clinic
      • Pekin, Illinois, 미국, 61554
        • Illinois CancerCare-Pekin
      • Peoria, Illinois, 미국, 61615
        • Illinois CancerCare-Peoria
      • Peru, Illinois, 미국, 61354
        • Illinois CancerCare-Peru
      • Princeton, Illinois, 미국, 61356
        • Illinois CancerCare-Princeton
      • Rockford, Illinois, 미국, 61104
        • Swedish American Hospital
      • Rockford, Illinois, 미국, 61114
        • UW Health Carbone Cancer Center Rockford
      • Springfield, Illinois, 미국, 62781
        • Springfield Memorial Hospital
      • Urbana, Illinois, 미국, 61801
        • Carle Cancer Center
    • Indiana
      • Merrillville, Indiana, 미국, 46410
        • Premier Oncology Hematology Associates
    • Iowa
      • Ames, Iowa, 미국, 50010
        • McFarland Clinic - Ames
      • Iowa City, Iowa, 미국, 52242
        • University of Iowa/Holden Comprehensive Cancer Center
      • Sioux City, Iowa, 미국, 51101
        • Siouxland Regional Cancer Center
      • Waterloo, Iowa, 미국, 50702
        • MercyOne Waterloo Cancer Center
    • Kansas
      • Kansas City, Kansas, 미국, 66160
        • University of Kansas Cancer Center
      • Prairie Village, Kansas, 미국, 66208
        • Kansas City NCI Community Oncology Research Program
      • Topeka, Kansas, 미국, 66606
        • Cotton O'Neil Cancer Center / Stormont Vail Health
    • Kentucky
      • Lexington, Kentucky, 미국, 40536
        • University of Kentucky/Markey Cancer Center
    • Louisiana
      • Baton Rouge, Louisiana, 미국, 70809
        • Ochsner Health Center-Summa
      • New Orleans, Louisiana, 미국, 70121
        • Ochsner Medical Center Jefferson
      • Shreveport, Louisiana, 미국, 71103
        • LSU Health Sciences Center at Shreveport
    • Maine
      • Bangor, Maine, 미국, 04401
        • Eastern Maine Medical Center
    • Maryland
      • Baltimore, Maryland, 미국, 21287
        • Johns Hopkins University/Sidney Kimmel Cancer Center
      • Elkton, Maryland, 미국, 21921
        • Christiana Care - Union Hospital
    • Massachusetts
      • Boston, Massachusetts, 미국, 02215
        • Dana-Farber Cancer Institute
      • Boston, Massachusetts, 미국, 02114
        • Massachusetts General Hospital Cancer Center
      • Brighton, Massachusetts, 미국, 02135
        • Dana-Farber Cancer Institute at Boston Medical Center - Brighton
      • Springfield, Massachusetts, 미국, 01199
        • Baystate Medical Center
      • Worcester, Massachusetts, 미국, 01655
        • UMass Memorial Medical Center - University Campus
    • Michigan
      • Ann Arbor, Michigan, 미국, 48106
        • Michigan Cancer Research Consortium NCORP
      • Ann Arbor, Michigan, 미국, 48106
        • Trinity Health Saint Joseph Mercy Hospital Ann Arbor
      • Battle Creek, Michigan, 미국, 49017
        • Bronson Battle Creek
      • Detroit, Michigan, 미국, 48201
        • Wayne State University/Karmanos Cancer Institute
      • Detroit, Michigan, 미국, 48236
        • Henry Ford Health Saint John Hospital
      • Escanaba, Michigan, 미국, 49829
        • OSF Saint Francis Hospital and Medical Group
      • Grand Rapids, Michigan, 미국, 49503
        • Cancer Research Consortium of West Michigan NCORP
      • Grand Rapids, Michigan, 미국, 49503
        • Trinity Health Grand Rapids Hospital
      • Grand Rapids, Michigan, 미국, 49503
        • Corewell Health Grand Rapids Hospitals - Butterworth Hospital
      • Kalamazoo, Michigan, 미국, 49007
        • West Michigan Cancer Center
      • Muskegon, Michigan, 미국, 49444
        • Trinity Health Muskegon Hospital
      • Port Huron, Michigan, 미국, 48060
        • Lake Huron Medical Center
      • Reed City, Michigan, 미국, 49677
        • Corewell Health Reed City Hospital
      • Traverse City, Michigan, 미국, 49684
        • Munson Medical Center
      • Warren, Michigan, 미국, 48093
        • Henry Ford Health Warren Hospital
    • Minnesota
      • Bemidji, Minnesota, 미국, 56601
        • Sanford Joe Lueken Cancer Center
      • Burnsville, Minnesota, 미국, 55337
        • Fairview Ridges Hospital
      • Coon Rapids, Minnesota, 미국, 55433
        • Mercy Hospital
      • Duluth, Minnesota, 미국, 55805
        • Essentia Health Cancer Center
      • Edina, Minnesota, 미국, 55435
        • Fairview Southdale Hospital
      • Fridley, Minnesota, 미국, 55432
        • Unity Hospital
      • Hutchinson, Minnesota, 미국, 55350
        • Hutchinson Area Health Care
      • Maplewood, Minnesota, 미국, 55109
        • Saint John's Hospital - Healtheast
      • Maplewood, Minnesota, 미국, 55109
        • Minnesota Oncology Hematology PA-Maplewood
      • Minneapolis, Minnesota, 미국, 55415
        • Hennepin County Medical Center
      • Minneapolis, Minnesota, 미국, 55407
        • Abbott-Northwestern Hospital
      • Minneapolis, Minnesota, 미국, 55417
        • Minneapolis VA Medical Center
      • Robbinsdale, Minnesota, 미국, 55422
        • North Memorial Medical Health Center
      • Rochester, Minnesota, 미국, 55905
        • Mayo Clinic in Rochester
      • Saint Cloud, Minnesota, 미국, 56303
        • Coborn Cancer Center at Saint Cloud Hospital
      • Saint Louis Park, Minnesota, 미국, 55416
        • Park Nicollet Clinic - Saint Louis Park
      • Saint Louis Park, Minnesota, 미국, 55416
        • Metro Minnesota Community Oncology Research Consortium
      • Saint Paul, Minnesota, 미국, 55101
        • Regions Hospital
      • Saint Paul, Minnesota, 미국, 55102
        • United Hospital
      • Shakopee, Minnesota, 미국, 55379
        • Saint Francis Regional Medical Center
      • Stillwater, Minnesota, 미국, 55082
        • Lakeview Hospital
      • Waconia, Minnesota, 미국, 55387
        • Ridgeview Medical Center
      • Willmar, Minnesota, 미국, 56201
        • Rice Memorial Hospital
      • Woodbury, Minnesota, 미국, 55125
        • Minnesota Oncology Hematology PA-Woodbury
    • Mississippi
      • Jackson, Mississippi, 미국, 39216
        • University of Mississippi Medical Center
    • Missouri
      • Cape Girardeau, Missouri, 미국, 63703
        • Saint Francis Medical Center
      • Columbia, Missouri, 미국, 65201
        • Veterans Administration
      • Columbia, Missouri, 미국, 65212
        • MU Health - University Hospital/Ellis Fischel Cancer Center
      • Kansas City, Missouri, 미국, 64111
        • Saint Luke's Hospital of Kansas City
      • St Louis, Missouri, 미국, 63141
        • Mercy Hospital Saint Louis
      • St Louis, Missouri, 미국, 63141
        • Saint Louis-Cape Girardeau CCOP
    • Montana
      • Billings, Montana, 미국, 59101
        • Billings Clinic Cancer Center
      • Bozeman, Montana, 미국, 59715
        • Bozeman Health Deaconess Hospital
    • New Jersey
      • Camden, New Jersey, 미국, 08103
        • Cooper Hospital University Medical Center
    • New Mexico
      • Albuquerque, New Mexico, 미국, 87106
        • University of New Mexico Cancer Center
      • Albuquerque, New Mexico, 미국, 87110
        • Presbyterian Kaseman Hospital
    • New York
      • Buffalo, New York, 미국, 14263
        • Roswell Park Cancer Institute
      • Lake Success, New York, 미국, 11042
        • Northwell Health/Center for Advanced Medicine
      • Manhasset, New York, 미국, 11030
        • North Shore University Hospital
      • Mineola, New York, 미국, 11501
        • NYU Langone Hospital - Long Island
      • New York, New York, 미국, 10065
        • NYP/Weill Cornell Medical Center
      • Rochester, New York, 미국, 14642
        • University of Rochester
      • The Bronx, New York, 미국, 10467
        • Montefiore Medical Center - Moses Campus
      • The Bronx, New York, 미국, 10461
        • Montefiore Medical Center-Weiler Hospital
    • North Carolina
      • Asheboro, North Carolina, 미국, 27203
        • Randolph Hospital
      • Goldsboro, North Carolina, 미국, 27534
        • Wayne Memorial Hospital
      • Greensboro, North Carolina, 미국, 27403
        • Cone Health Cancer Center
      • Hendersonville, North Carolina, 미국, 28791
        • Margaret R Pardee Memorial Hospital
      • Kinston, North Carolina, 미국, 28501
        • ECU Health Oncology Kinston
      • Pinehurst, North Carolina, 미국, 28374
        • FirstHealth of the Carolinas-Moore Regional Hospital
      • Reidsville, North Carolina, 미국, 27320
        • Annie Penn Memorial Hospital
      • Statesville, North Carolina, 미국, 28677
        • Iredell Memorial Hospital
      • Winston-Salem, North Carolina, 미국, 27104
        • Southeast Clinical Oncology Research Consortium NCORP
    • North Dakota
      • Bismarck, North Dakota, 미국, 58501
        • Sanford Bismarck Medical Center
      • Bismarck, North Dakota, 미국, 58501
        • Mid Dakota Clinic
      • Fargo, North Dakota, 미국, 58122
        • Sanford Roger Maris Cancer Center
      • Fargo, North Dakota, 미국, 58122
        • Sanford Broadway Medical Center
    • Ohio
      • Beachwood, Ohio, 미국, 44122
        • Cleveland Clinic Cancer Center Beachwood
      • Cincinnati, Ohio, 미국, 45219
        • University of Cincinnati Cancer Center-UC Medical Center
      • Cleveland, Ohio, 미국, 44106
        • Case Western Reserve University
      • Cleveland, Ohio, 미국, 44195
        • Cleveland Clinic Foundation
      • Cleveland, Ohio, 미국, 44111
        • Cleveland Clinic Cancer Center/Fairview Hospital
      • Columbus, Ohio, 미국, 43214
        • Riverside Methodist Hospital
      • Columbus, Ohio, 미국, 43219
        • The Mark H Zangmeister Center
      • Columbus, Ohio, 미국, 43222
        • Mount Carmel Health Center West
      • Columbus, Ohio, 미국, 43215
        • Columbus NCI Community Oncology Research Program
      • Dayton, Ohio, 미국, 45409
        • Miami Valley Hospital
      • Independence, Ohio, 미국, 44131
        • Cleveland Clinic Cancer Center Independence
      • Marietta, Ohio, 미국, 45750
        • Marietta Memorial Hospital
      • Mayfield Heights, Ohio, 미국, 44124
        • Hillcrest Hospital Cancer Center
      • Newark, Ohio, 미국, 43055
        • Licking Memorial Hospital
      • Parma, Ohio, 미국, 44129
        • University Hospitals Parma Medical Center
      • Sandusky, Ohio, 미국, 44870
        • North Coast Cancer Care
      • Springfield, Ohio, 미국, 45504
        • Springfield Regional Medical Center
      • Strongsville, Ohio, 미국, 44136
        • Cleveland Clinic Cancer Center Strongsville
      • Sylvania, Ohio, 미국, 43560
        • ProMedica Flower Hospital
      • Toledo, Ohio, 미국, 43614
        • University of Toledo
      • Westerville, Ohio, 미국, 43081
        • Saint Ann's Hospital
      • Wooster, Ohio, 미국, 44691
        • Cleveland Clinic Wooster Family Health and Surgery Center
    • Oklahoma
      • Norman, Oklahoma, 미국, 73071
        • Cancer Care Associates-Norman
      • Oklahoma City, Oklahoma, 미국, 73104
        • University of Oklahoma Health Sciences Center
      • Oklahoma City, Oklahoma, 미국, 73120
        • Mercy Hospital Oklahoma City
    • Oregon
      • Gresham, Oregon, 미국, 97030
        • Legacy Mount Hood Medical Center
      • Milwaukie, Oregon, 미국, 97222
        • Providence Milwaukie Hospital
      • Newberg, Oregon, 미국, 97132
        • Providence Newberg Medical Center
      • Oregon City, Oregon, 미국, 97045
        • Providence Willamette Falls Medical Center
      • Portland, Oregon, 미국, 97210
        • Legacy Good Samaritan Hospital and Medical Center
      • Portland, Oregon, 미국, 97213
        • Providence Portland Medical Center
      • Portland, Oregon, 미국, 97225
        • Providence Saint Vincent Medical Center
    • Pennsylvania
      • Allentown, Pennsylvania, 미국, 18103
        • Lehigh Valley Hospital-Cedar Crest
      • Carlisle, Pennsylvania, 미국, 17015
        • Carlisle Regional Cancer Center
      • Danville, Pennsylvania, 미국, 17822
        • Geisinger Medical Center
      • Doylestown, Pennsylvania, 미국, 18901
        • Doylestown Hospital
      • Hazleton, Pennsylvania, 미국, 18201
        • Geisinger Medical Center-Cancer Center Hazleton
      • Hershey, Pennsylvania, 미국, 17033-0850
        • Penn State Milton S Hershey Medical Center
      • Pittsburgh, Pennsylvania, 미국, 15232
        • UPMC Hillman Cancer Center
      • Sayre, Pennsylvania, 미국, 18840
        • Guthrie Medical Group PC-Robert Packer Hospital
      • West Reading, Pennsylvania, 미국, 19611
        • Reading Hospital
      • Wilkes-Barre, Pennsylvania, 미국, 18711
        • Geisinger Wyoming Valley/Henry Cancer Center
    • South Carolina
      • Boiling Springs, South Carolina, 미국, 29316
        • Prisma Health Cancer Institute - Spartanburg
      • Charleston, South Carolina, 미국, 29401
        • Roper Hospital
      • Greenville, South Carolina, 미국, 29605
        • Prisma Health Cancer Institute - Faris
      • Greenville, South Carolina, 미국, 29615
        • Prisma Health Cancer Institute - Eastside
      • Greenville, South Carolina, 미국, 29605
        • Prisma Health Cancer Institute - Butternut
      • Greenville, South Carolina, 미국, 29601
        • Saint Francis Hospital
      • Greenville, South Carolina, 미국, 29605
        • Prisma Health Greenville Memorial Hospital
      • Seneca, South Carolina, 미국, 29672
        • Prisma Health Cancer Institute - Seneca
      • Spartanburg, South Carolina, 미국, 29303
        • Spartanburg Medical Center
    • South Dakota
      • Rapid City, South Dakota, 미국, 57701
        • Rapid City Regional Hospital
      • Sioux Falls, South Dakota, 미국, 57117-5134
        • Sanford USD Medical Center - Sioux Falls
      • Sioux Falls, South Dakota, 미국, 57104
        • Sanford Cancer Center Oncology Clinic
    • Tennessee
      • Knoxville, Tennessee, 미국, 37916
        • Covenant Health Cancer Centers
      • Nashville, Tennessee, 미국, 37232
        • Vanderbilt University/Ingram Cancer Center
    • Texas
      • Amarillo, Texas, 미국, 79106
        • The Don and Sybil Harrington Cancer Center
      • Dallas, Texas, 미국, 75390
        • UT Southwestern/Simmons Cancer Center-Dallas
    • Utah
      • Salt Lake City, Utah, 미국, 84112
        • Huntsman Cancer Institute/University of Utah
    • Virginia
      • Martinsville, Virginia, 미국, 24112
        • Sovah Health Martinsville
    • Washington
      • Vancouver, Washington, 미국, 98664
        • PeaceHealth Southwest Medical Center
    • West Virginia
      • Morgantown, West Virginia, 미국, 26506
        • West Virginia University Healthcare
    • Wisconsin
      • Chippewa Falls, Wisconsin, 미국, 54729
        • Marshfield Clinic-Chippewa Center
      • Eau Claire, Wisconsin, 미국, 54701
        • HSHS Sacred Heart Hospital
      • Eau Claire, Wisconsin, 미국, 54701
        • Marshfield Clinic Cancer Center at Sacred Heart
      • Green Bay, Wisconsin, 미국, 54311
        • Aurora BayCare Medical Center
      • Green Bay, Wisconsin, 미국, 54301
        • Saint Vincent Hospital Cancer Center Green Bay
      • Green Bay, Wisconsin, 미국, 54303
        • Saint Vincent Hospital Cancer Center at Saint Mary's
      • Green Bay, Wisconsin, 미국, 54301-3526
        • Green Bay Oncology at Saint Vincent Hospital
      • Janesville, Wisconsin, 미국, 53548
        • Mercyhealth Hospital and Cancer Center - Janesville
      • La Crosse, Wisconsin, 미국, 54601
        • Gundersen Lutheran Medical Center
      • Madison, Wisconsin, 미국, 53715
        • SSM Health Dean Medical Group - South Madison Campus
      • Marinette, Wisconsin, 미국, 54143
        • Aurora Bay Area Medical Group-Marinette
      • Marinette, Wisconsin, 미국, 54143
        • Bay Area Medical Center
      • Marshfield, Wisconsin, 미국, 54449
        • Marshfield Medical Center-Marshfield
      • Marshfield, Wisconsin, 미국, 54449
        • Marshfield Medical Center
      • Milwaukee, Wisconsin, 미국, 53226
        • Medical College of Wisconsin
      • Minocqua, Wisconsin, 미국, 54548
        • Marshfield Medical Center - Minocqua
      • Oconomowoc, Wisconsin, 미국, 53066
        • ProHealth Oconomowoc Memorial Hospital
      • Oconto Falls, Wisconsin, 미국, 54154
        • Saint Vincent Hospital Cancer Center at Oconto Falls
      • Rhinelander, Wisconsin, 미국, 54501
        • Aspirus Cancer Care-Rhinelander-James Beck Cancer Center
      • Rice Lake, Wisconsin, 미국, 54868
        • Marshfield Medical Center-Rice Lake
      • Stevens Point, Wisconsin, 미국, 54481
        • Aspirus Cancer Care - Stevens Point
      • Summit, Wisconsin, 미국, 53066
        • Aurora Medical Center in Summit
      • Waukesha, Wisconsin, 미국, 53188
        • ProHealth Waukesha Memorial Hospital
      • Wauwatosa, Wisconsin, 미국, 53226
        • Aurora Cancer Care-Milwaukee West
      • Weston, Wisconsin, 미국, 54476
        • Marshfield Medical Center - Weston
      • Wisconsin Rapids, Wisconsin, 미국, 54494
        • Marshfield Clinic - Wisconsin Rapids Center
    • Alberta
      • Calgary, Alberta, 캐나다, T2N 5G2
        • Arthur J E Child Comprehensive Cancer Centre
    • British Columbia
      • Vancouver, British Columbia, 캐나다, V5Z 3P1
        • Clinical Research Unit at Vancouver Coastal Health Authority
    • Manitoba
      • Winnipeg, Manitoba, 캐나다, R3E 0V9
        • CancerCare Manitoba
    • New Brunswick
      • Moncton, New Brunswick, 캐나다, E1C 6Z8
        • The Moncton Hospital
      • Saint John, New Brunswick, 캐나다, E2L 4L2
        • Atlantic Health Sciences Corporation-Saint John Regional Hospital
    • Nova Scotia
      • Halifax, Nova Scotia, 캐나다, B3H 2Y9
        • QEII Health Sciences Centre/Nova Scotia Health Authority
    • Ontario
      • Hamilton, Ontario, 캐나다, L8V 5C2
        • Juravinski Cancer Centre at Hamilton Health Sciences
      • Toronto, Ontario, 캐나다, M5G 2M9
        • University Health Network-Princess Margaret Hospital
      • Toronto, Ontario, 캐나다, M4N 3M5
        • Odette Cancer Centre- Sunnybrook Health Sciences Centre
    • Quebec
      • Greenfield Park, Quebec, 캐나다, J4V 2H1
        • CSSS Champlain-Charles Le Moyne
      • Montreal, Quebec, 캐나다, H3H 2R9
        • The Research Institute of the McGill University Health Centre (MUHC)
      • Montreal, Quebec, 캐나다, H2W 1S6
        • McGill University Department of Oncology
    • Saskatchewan
      • Regina, Saskatchewan, 캐나다, S4T 7T1
        • Allan Blair Cancer Centre
      • Saskatoon, Saskatchewan, 캐나다, S7N 4H4
        • Saskatoon Cancer Centre

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

18년 이상 (성인, 고령자)

건강한 자원 봉사자를 받아들입니다

아니

연구 대상 성별

모두

설명

Inclusion Criteria:

  • Patients must have morphologically confirmed diagnosis of myelodysplastic syndrome (MDS) or chronic myelomonocytic leukemia (CMML) based on one of the following:

    • French-American-British (FAB) classifications:

      • Refractory anemia with excess blasts (RAEB - defined as having 5-20% myeloblasts in the bone marrow)
      • Chronic myelomonocytic leukemia (CMML) with 10-19% myeloblasts in the bone marrow and/or 5-19% blasts in the blood
    • World Health Organization (WHO) classifications:

      • Refractory anemia with excess blasts-1 (RAEB-1 - defined as having 5-9% myeloblasts in the bone marrow)
      • Refractory anemia with excess blasts-2 (RAEB-2 - defined as having 10-19% myeloblasts in the bone marrow and/or 5-19% blasts in the blood)
      • Chronic myelomonocytic leukemia-1 (CMML-1 - defined as having < 10% myeloblasts in the bone marrow and/or < 5% blasts in the blood)
      • Chronic myelomonocytic leukemia-2 (CMML-2 - defined as having 10-19% myeloblasts in the bone marrow and/or 5-19% blasts in the blood) OR
    • International prognostic score (IPSS) of intermediate 2 (1.5-2.0 points) or high (>= 2.5 points); a score of intermediate 1 (0.5-1.0 points) is only allowable in the setting of >= 5% myeloblasts

    • NOTE: Patients with acute myeloid leukemia (AML) are not eligible

    • Procedures to obtain specimens for establishing baseline disease must be done within 30 days prior to registration

  • Patients must not have received lenalidomide, azacitidine, vorinostat, or decitabine as treatment previously; any hematopoietic growth factors must be stopped for at least 14 days prior to registration; patients may have received low-dose cytarabine for MDS treatment previously, but they must have discontinued its use for at least 28 days prior to registration; patients may have received prior hydroxyurea per CMML treatment previously, but they must have discontinued its use for at least 7 days prior to registration; these patients will not be eligible if white blood cell (WBC) > 30,000/mm^3

  • Patients must not have received radiation therapy, chemotherapy, or cytotoxic therapy to treat conditions other than MDS within 12 months prior to registration

  • Patients must not have undergone prior allogeneic stem cell or bone marrow transplantation at any time; patients that have undergone an autologous stem cell transplant are eligible

  • Patients must not have used or be using histone deacetylase (HDAC) inhibitor agents for anticancer treatment

  • Patients may not have received agents such as valproic acid for epilepsy within 30 days prior to registration

  • Patients must have Zubrod performance status of 0-2

  • Patients must not have any pre-existing neurotoxicity/neuropathy of >= grade 2 according to the National Cancer Institute (NCI) Common Toxicity Criteria version 4.0, or prior >= grade 3 allergic reaction/hypersensitivity or rash to thalidomide, that has not resolved to < grade 2

  • Patients must not have any serious medical condition, laboratory abnormality, or psychiatric illness that, in the view of the treating physician, would place the participant at an unacceptable risk if he or she were to participate in the study or would prevent that person from giving informed consent

  • Patients must not have history of thromboembolic event or other condition requiring current use of anticoagulation with Coumadin (warfarin) or low molecular-weight heparin

  • Patients must not have known or suspected hypersensitivity to mannitol

  • Patients must receive a 12-lead electrocardiogram (EKG), chest x-ray or computed tomography (CT) scan, serum creatinine, complete metabolic panel including serum glutamic oxaloacetic transaminase (SGOT) or serum glutamate pyruvate transaminase (SGPT), electrolytes, and bilirubin testing within 28 days prior to registration in order to establish baseline measurements; questions regarding patient safety in regards to results of these tests should be directed to the study chair

  • Females of childbearing potential (FCBP) must have a negative serum or urine pregnancy test with a sensitivity of at least 25 mIU/mL within 10 - 14 days prior to registration; FCBP must agree to have a second pregnancy test within 24 hours prior to starting cycle 1 if randomized to receive lenalidomide

    • Further, patients commit to the following if they are randomized to receive lenalidomide: FCBP must either commit to continued abstinence from heterosexual intercourse or begin TWO acceptable methods of birth control: one highly effective method and one additional effective method AT THE SAME TIME, at least 28 days before starting lenalidomide; FCBP must also agree to ongoing pregnancy testing; men must agree to use a latex condom during sexual contact with a FCBP, even if they have had a successful vasectomy; a FCBP is a sexually mature woman who: 1) has not undergone a hysterectomy or bilateral oophorectomy; or 2) has not been naturally postmenopausal for at least 24 consecutive months (i.e., has had menses at any time in the preceding 24 consecutive months); all patients must be counseled by a trained counselor every 28 days about pregnancy precautions and risks of fetal exposure
    • NOTE: Patients not randomized to receive lenalidomide will not be required to undergo serial pregnancy testing or lenalidomide counseling after registration
  • No prior malignancy is allowed except for adequately treated basal cell (or squamous cell) skin cancer, in situ cervical cancer, or other cancer for which the patient has been disease-free for three years

  • Cytogenetics requirements:

    • Southwestern Oncology Group (SWOG) (and other sites not affiliated with Alliance or Eastern Cooperative Oncology Group [ECOG]-American College of Radiology Imaging Network [ACRIN]): Pretreatment cytogenetics must be performed on all patients; collection of pretreatment specimens must be completed within 30 days prior to registration to S1117; specimens must be submitted to the site's preferred Clinical Laboratory Improvement Amendments (CLIA)-approved cytogenetics laboratory; reports of the results must be submitted as described; note that cytogenetics are required at other timepoints; NOTE: National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) sites may submit specimens to College of American Pathologists (CAP) or Ontario Laboratory Accreditation (OLA)-approved laboratories providing the lab is licensed to perform fluorescent in situ hybridization (FISH) analysis
    • Alliance: Alliance patients must enroll on Cancer and Leukemia Group B (CALGB) 8461, the cytogenetics protocol; CALGB 8461 provides sample procurement and submission instructions to Alliance-approved institutional cytogeneticists; note that cytogenetics are required at other timepoints
    • ECOG-ACRIN: Pretreatment cytogenetics must be performed on all patients; collection of pretreatment specimens must be completed within 30 days prior to registration to S1117; specimens must be submitted to the site's preferred CLIA-approved cytogenetics laboratory; karyotypes and reports must be submitted for review to the Mayo Clinic Cytogenetics Laboratory in Rochester; note that cytogenetics testing is required at other timepoints
  • Banking requirements:

    • SWOG, Alliance and ECOG-ACRIN (and other sites not affiliated with NCIC CTG): Patients must be offered participation in specimen banking; with patient consent, specimens must be submitted as outlined
    • Alliance: (Temporarily Closed 2/28/14): As of February 28, 2014, CALGB 9665 has been temporarily closed, so Alliance patients under consideration for S1117 are NOT to be registered to CALGB 9665 and no specimens for patients enrolled after February 28, 2014 are to be submitted via this ancillary study; these patients should submit specimens per SWOG instructions; patients already enrolled on CALGB 9665 should continue to submit specimens per instructions in CALGB 9665
    • NCIC CTG: NCIC CTG patients must be offered participation in specimen submission and banking; with patient consent, specimens must be submitted as outlined
  • All patients or their legally authorized representative must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines

  • As a part of the Oncology Patient Enrollment Network (OPEN) registration process the treating institution's identity is provided in order to ensure that the current (within 365 days) date of institutional review board approval for this study has been entered in the system

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 치료
  • 할당: 무작위
  • 중재 모델: 병렬 할당
  • 마스킹: 없음(오픈 라벨)

무기와 개입

참가자 그룹 / 팔
개입 / 치료
실험적: Arm I (azacitidine and lenalidomide)

Patients receive azacitidine SC or IV on days 1-7 or days 1-5 and 8-9, and lenalidomide PO QD on days 1-21. Courses repeat every 28 days for up to 5 years in the absence of disease progression or unacceptable toxicity.

Correlative studies

Given PO

다른 이름들:
  • CC-5013
  • 레블리미드
  • CC5013
  • CDC 501
  • CC 5013

Given SC or IV

다른 이름들:
  • 5 AZC
  • 5-AC
  • 5-아자시티딘
  • 5-AZC
  • 아자시티딘
  • 아자시티딘, 5-
  • 라다카마이신
  • 마일로사르
  • U-18496
  • 비다자
실험적: Arm II (azacitidine)

Patients receive azacitidine as in Arm I. Courses repeat every 28 days for up to 5 years in the absence of disease progression or unacceptable toxicity.

Correlative studies

Given SC or IV

다른 이름들:
  • 5 AZC
  • 5-AC
  • 5-아자시티딘
  • 5-AZC
  • 아자시티딘
  • 아자시티딘, 5-
  • 라다카마이신
  • 마일로사르
  • U-18496
  • 비다자
실험적: Arm III (azacitidine and vorinostat)

Patients receive azacitidine as in Arm I and vorinostat PO BID on days 3-9. Courses repeat every 28 days for up to 5 years in the absence of disease progression or unacceptable toxicity.

Correlative studies

Given SC or IV

다른 이름들:
  • 5 AZC
  • 5-AC
  • 5-아자시티딘
  • 5-AZC
  • 아자시티딘
  • 아자시티딘, 5-
  • 라다카마이신
  • 마일로사르
  • U-18496
  • 비다자

Given PO

다른 이름들:
  • 사하
  • 수베로일아닐리드 하이드록삼산
  • MSK-390
  • 졸린자
  • L-001079038
  • 수베라닐로히드록삼산

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Response Rate (Phase II)
기간: Up to 5 years

A response is any of complete hematological remission, partial remission, or hematologic improvement.

Up to 5 years
Overall Survival (Phase III)
기간: Up to 5 years

OS is calculated for all patients from the date of initial registration to date of death due to any cause. The follow-up for patients last known to be alive is censored at the date of last contact. Stratified Cox regression models will be used to compare OS of the combination arm selected in the Phase II portion of the trial to OS of the single-agent azacitidine arm.

Up to 5 years

2차 결과 측정

결과 측정
측정값 설명
기간
Relapse-free Survival
기간: Up to 5 years

RFS is calculated for patients who have achieved a response. RFS will be measured from the date of response to the date of first documentation of relapse from response (as defined in the primary objective), or death due to any cause. The follow-up for patients last known to be alive and without report of relapse is censored at the date of last contact. RFS will be estimated for each of the three arms using the Kaplan-Meier method.

Up to 5 years
Overall Survival
기간: Up to 5 years

OS is calculated for all patients from the date of initial registration to date of death due to any cause. The follow- up for patients last known to be alive is censored at the date of last contact. OS will be estimated for each of the three arms using the Kaplan-Meier method.

Up to 5 years
Pre-study Cytogenetic Abnormalities
기간: Up to 5 years

Cytogenetic risk group is used to identify cytogenetic abnormalities.

Up to 5 years
Toxicity Rate
기간: Up to 5 years

Adverse events that are possibly, probably or definitely related to study drug are reported.

Up to 5 years

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

수사관

  • 수석 연구원: Mikkael A Sekeres, SWOG Cancer Research Network

간행물 및 유용한 링크

연구에 대한 정보 입력을 담당하는 사람이 자발적으로 이러한 간행물을 제공합니다. 이것은 연구와 관련된 모든 것에 관한 것일 수 있습니다.

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (실제)

2012년 3월 1일

기본 완료 (실제)

2015년 6월 1일

연구 완료 (추정된)

2027년 3월 31일

연구 등록 날짜

최초 제출

2012년 1월 27일

QC 기준을 충족하는 최초 제출

2012년 1월 27일

처음 게시됨 (추정된)

2012년 2월 1일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 11월 18일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 11월 17일

마지막으로 확인됨

2026년 9월 1일

추가 정보

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

구독하다